A population based study of radiotherapy in a cohort of patients with breast cancer diagnosed between 1996 and 2000

European Journal of Cancer

Volumn 43, Issue 13, 2007, Pages 1976-1982

  Vulto, J C M ^a   Louwman, W J ^b   Poortmans, P M P ^a   Lybeert, L M ^c   Rutten, H J T ^c   Coebergh, J W W ^b,d  

^a DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^b The Netherlands   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Population based; Radiotherapy; The Netherlands

Indexed keywords

ADULT; AGED; AGING; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; RADIOTHERAPY, ADJUVANT; SOCIOECONOMIC FACTORS;

EID: 34548119795     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.05.020     Document Type: Article

References (42)

1. Whelan T.J., Julian J., Wright J., Jadad A.R., and Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
2. Vinh-Hung V., and Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96 (2004) 115-121
3. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355 (2000) 1757-1770
4. van der Sangen M.J., Coebergh J.W., Roumen R.M., Rutten H.J., Vreugdenhil G., and Voogd A.C. Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma. Cancer 98 (2003) 11-17
5. McQuay H.J., Carroll D., and Moore R.A. Radiotherapy for painful bone metastases: a systematic review. Clin Oncol (R Coll Radiol) 9 (1997) 150-154
6. van Daal W.A., and Bos M.A. Infrastructure for radiotherapy in The Netherlands: development from 1970 to 2010. Int J Radiat Oncol Biol Phys 37 (1997) 411-415
7. Porter A., Aref A., Chodounsky Z., et al. A global strategy for radiotherapy: a WHO consultation. Clin Oncol (R Coll Radiol) 11 (1999) 368-370
8. Moller T.R., Brorsson B., Ceberg J., et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 42 (2003) 387-410
9. Vulto A., Louwman M., Rodrigus P., and Coebergh J.W. Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988-2002. Radiother Oncol 78 (2006) 131-137
10. Lybeert M.L., Louwman M., and Coebergh J.W. Stable overall referral rates of primary radiotherapy for newly diagnosed cancer patients in the ageing population of South-Eastern Netherlands, 1975-1998. Radiother Oncol 73 (2004) 101-108
11. de Jong B., Crommelin M., van der Heijden L.H., and Coebergh J.W. Patterns of radiotherapy for cancer patients in south-eastern Netherlands, 1975-1989. Radiother Oncol 31 (1994) 213-221
12. Foroudi F., Tyldesley S., Walker H., and Mackillop W.J. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys 53 (2002) 1240-1253
13. Delaney G., Barton M., and Jacob S. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer 98 (2003) 1977-1986
14. Schouten L.J., Hoppener P., van den Brandt P.A., Knottnerus J.A., and Jager J.J. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 22 (1993) 369-376
15. Vulto JCM, Louwman MW, Poortmans P, et al. population based study of radiotherapy in a cohort of patients with rectal cancer diagnosed between 1996 and 2000. Eur J Surg Oncol 2007, doi:10.1016/j.ejso.2007.02.019.
16. Vernon C.C., Hand J.W., Field S.B., et al., International Collaborative Hyperthermia Group. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 35 (1996) 731-744
17. Cutler S.J., and Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 8 (1958) 699-712
18. Hill D.J., White V.M., Giles G.G., Collins J.P., and Kitchen P.R. Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust 161 (1994) 110-111 [114, 118 passim]
19. Luke C., Chapman P., Priest K., and Roder D. Use of radiotherapy in the primary treatment of cancer in South Australia. Australas Radiol 47 (2003) 161-167
20. NSW radiotherapy management information system report 2000. Sydney: New South Wales Health Department; 2001. Statewise Services Development Branch 2001.
21. Manders K., van de Poll-Franse L.V., Creemers G.J., et al. Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer 6 (2006) 179
22. Vulto A.J., Lemmens V.E., Louwman M.W., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer 106 (2006) 2734-2742
23. Louwman W.J., Janssen-Heijnen M.L., Houterman S., et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population based study. Eur J Cancer 41 (2005) 779-785
24. Voti L., Richardson L.C., Reis I., Fleming L.E., Mackinnon J., and Coebergh J.W. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat 95 (2006) 89-95
25. Ministry of Health, Welfare and Sport; 2007. http://www.minvws.nl/dossiers/>zorgverzekering/onverzekerden [cited 15 March 2007].
26. Oncoline, oncological guidelines; 2007. http://www.oncoline.nl [cited 15 March 2007].
27. Bijker N., Meijnen P., Peterse J.L., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 (2006) 3381-3387
28. IKCnet, Network of knowledge of the Comprehensive Cancer Centers; 2006. www.ikcnet.nl [cited 15 March 2007].
29. Gao X., Fisher S.G., and Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population based study. Int J Radiat Oncol Biol Phys 56 (2003) 1038-1045
30. Vulto J.C., Louwman W.J., Poortmans P.M., and Coebergh J.W. Hospital variation in referral for primary radiotherapy in South Netherlands, 1988-1999. Eur J Cancer 41 (2005) 2722-2727
31. Siesling S., van de Poll-Franse L.V., Jobsen J.J., Repelaer van Driel O.J., and Voogd A.C. Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period 1990-2002. Ned Tijdschr Geneeskd 149 (2005) 1941-1946
32. Coleman R.E., and Rubens R.D. The clinical course of bone metastases from breast cancer. Br J Cancer 55 (1987) 61-66
33. Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastases. Bone 12 Suppl. 1 (1991) S9-S10
34. Nielsen O.S., Munro A.J., and Tannock I.F. Bone metastases: pathophysiology and management policy. J Clin Oncol 9 (1991) 509-524
35. van der Linden Y.M., Steenland E., van Houwelingen H.C., et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. Radiother Oncol 78 (2006) 245-253
36. Rades D., Veninga T., Stalpers L.J., et al. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys 64 (2006) 182-188
37. Lin N.U., Bellon J.R., and Winer E.P. CNS metastases in breast cancer. J Clin Oncol 22 (2004) 3608-3617
38. van der Sangen M.J., van de Poll-Franse L.V., Roumen R.M., et al. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol 32 (2006) 34-38
39. van Tienhoven G., Voogd A.C., Peterse J.L., et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 35 (1999) 32-38
40. Holzel D., Engel J., Schmidt M., and Sauer H. A model for primary and secondary metastasis in breast cancer and the clinical consequences. Strahlenther Onkol 177 (2001) 10-24
41. Chung C.T., and Carlson R.W. Goals and objectives in the management of metastatic breast cancer. Oncologist 8 (2003) 514-520
42. Solomayer E.F., Diel I.J., Meyberg G.C., Gollan C., and Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59 (2000) 271-288